An authenticity survey of herbal medicines from markets in China using DNA barcoding

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Han, Jianping ^a   Pang, Xiaohui ^a   Liao, Baosheng ^a   Yao, Hui ^a   Song, Jingyuan ^a   Chen, Shilin ^b  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN CORTEX; BUPLEURUM; CHINA; CHINESE MEDICINE; DATA BASE; DNA BARCODING; GINSENG; HERBAL MEDICINE; HUMAN; MAJOR CLINICAL STUDY; MARKET; MEDICINAL SPECIES; RHIZOME; CLASSIFICATION; DNA SEQUENCE; MEDICINAL PLANT; POLYMERASE CHAIN REACTION; STANDARDS;

CHINA; DNA BARCODING, TAXONOMIC; HERBAL MEDICINE; MEDICINE, CHINESE TRADITIONAL; PLANTS, MEDICINAL; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 84954521631     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep18723     Document Type: Article

References (47)

1. Chan, T. Y. Incidence of Herb-Induced Aconitine Poisoning in Hong Kong. Drug Saf. 25, 823-828 (2002).
2. Lowe, L., Matteucci, M. J., Schneir, A. B. Herbal aconite tea and refractory ventricular tachycardia. N. Engl. J. Med. 353, 1532-1532 (2005).
3. Poon, W. T. et al. Aconite poisoning in camouflage. Hong Kong Med. J. 12, 456-459 (2006).
4. Fotiou, F., Aravind, S., Wang, P., Nerapusee, O. Impact of illegal trade on the quality of epoetin alfa in Thailand. Clin. Ther. 31, 336-346 (2009).
5. Gautam, C., Utreja, A., Singal, G. Spurious and counterfeit drugs: a growing industry in the developing world. Postgrad. Med. J. 85, 251-256 (2009).
6. Organization, W. H. Medicines: spurious/falsely-labelled/falsified/counterfeit (SFFC) medicines. (2012), Available at: http://www.who. int/mediacentre/factsheets/fs275/en/. (Date of access: 02/01/2015).
7. Garuba, H. A., Kohler, J. C., Huisman, A. M. Transparency in Nigeria's public pharmaceutical sector: perceptions from policy makers. Global Health 5, 14 (2009).
8. Dégardin, K., Roggo, Y., Margot, P. Understanding and fighting the medicine counterfeit market. J. Pharm. Biomed. Anal. 87, 167-175 (2014).
9. Marini, R. et al. Reliable low-cost capillary electrophoresis device for drug quality control and counterfeit medicines. J. Pharm. Biomed. Anal. 53, 1278-1287 (2010).
10. Busse, W. The significance of quality for efficacy and safety of herbal medicinal products. Drug Inf. J. 34, 15-23 (2000).
11. De Smet, P. A. Health risks of herbal remedies: an update. Clin. Pharmacol. Ther. 76, 1-17 (2004).
12. Sperl, W. et al. Reversible hepatic veno-occlusive disease in an infant after consumption of pyrrolizidine-containing herbal tea. Eur. J. Pediatr. 154, 112-116 (1995).
13. Johanns, E. S. et al. [An epidemic of epileptic seizures after consumption of herbal tea]. Ned. Tijdschr. Geneeskd. 146, 813-816 (2002).
14. Chen, S. P. L. et al. Aconite Poisoning over 5 Years. Drug Saf. 35, 575-587 (2012).
15. Phua, D., Cham, G., Seow, E. Two instances of Chinese herbal medicine poisoning in Singapore. Singapore Med. J. 49, e131-133 (2008).
16. Dondorp, A. et al. Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials. Trop. Med. Int. Health 9, 1241-1246 (2004).
17. Lee, S. et al. Fanconi's syndrome and subsequent progressive renal failure caused by a Chinese herb containing aristolochic acid. Nephrology 9, 126-129 (2004).
18. Lo, S. H. K. et al. Aristolochic acid nephropathy complicating a patient with focal segmental glomerulosclerosis. Nephrol. Dial. Transplant. 19, 1913-1915 (2004).
19. Vanherweghem, J. L. et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 341, 387-391 (1993).
20. Xin, T. et al. Survey of commercial Rhodiola products revealed species diversity and potential safety issues. Sci. Rep. 5, 8337, doi: 10.1038/srep08337 (2015).
21. Panusa, A., Multari, G., Incarnato, G., Gagliardi, L. High-performance liquid chromatography analysis of anti-inflammatory pharmaceuticals with ultraviolet and electrospray-mass spectrometry detection in suspected counterfeit homeopathic medicinal products. J. Pharm. Biomed. Anal. 43, 1221-1227 (2007).
22. Puchert, T., Lochmann, D., Menezes, J., Reich, G. Near-infrared chemical imaging (NIR-CI) for counterfeit drug identification-a four-stage concept with a novel approach of data processing (Linear Image Signature). J. Pharm. Biomed. Anal. 51, 138-145 (2010).
23. Lindegårdh, N., Dondorp, A., Singhasivanon, P., White, N., Day, N. Validation and application of a liquid chromatographic-mass spectrometric method for determination of artesunate in pharmaceutical samples. J. Pharm. Biomed. Anal. 45, 149-153 (2007).
24. Hebert, P. D. N., Cywinska, A., Ball, S. L., deWaard, J. R. Biological identifications through DNA barcodes. Proc. R. Soc. London, Ser. B 270, 313-321 (2003).
25. Techen, N., Parveen, I., Pan, Z., Khan, I. A. DNA barcoding of medicinal plant material for identification. Curr. Opin. Biotechnol. 25, 103-110 (2014).
26. Hebert, P. D., Gregory, T. R. The promise of DNA barcoding for taxonomy. Syst. Biol. 54, 852-859 (2005).
27. Miller, S. E. DNA barcoding and the renaissance of taxonomy. Proc. Natl. Acad. Sci. USA 104, 4775-4776 (2007).
28. Chen, S. et al. Validation of the ITS2 region as a novel DNA barcode for identifying medicinal plant species. PLoS One 5, e8613 (2010).
29. Chen, S. et al. A renaissance in herbal medicine identification: from morphology to DNA. Biotechnol. Adv. 32, 1237-1244 (2014).
30. Administration, T. K. F. a. D. The Korean Pharmacopoeia. 10th ed., (KFDA press, 2012).
31. Commission, E. P. European Pharmacopoeia. 8th ed., (Directorate for the Quality of Medicines & HealthCare of the Council of Europe (EDQM), 2013).
32. Committee, J. P. E. Japanese Pharmacopoeia. 16th ed., (The Ministry of Health, Labour and Welfare, 2011).
33. Committee, N. P. Chinese Pharmacopoeia. 2010th ed., (China Medical Science Press, 2010).
34. Convention, U. S. P. U.S. Pharmacopeia 36/National Formulary 31. (U.S. Pharmacopeial Convention Incorporation, 2013).
35. IP, C. Indian Pharmacopoeia. 2010th ed., (The Indian Pharmacopoeia Commission, 2010).
36. Han, J. et al. The short ITS2 sequence serves as an efficient taxonomic sequence tag in comparison with the full-length ITS. BioMed Res. Int. 2013 (2013).
37. Kool, A. et al. Molecular identification of commercialized medicinal plants in Southern Morocco. PloS one 7, e39459 (2012).
38. Ross, H. A., Murugan, S., Li, W. L. S. Testing the reliability of genetic methods of species identification via simulation. Systematic biology 57, 216-230 (2008).
39. Han, J. et al. Relationship between DNA Barcoding and Chemical Classification of Salvia Medicinal Herbs. Chin. Herb. Med. 2, 16-29 (2010).
40. Espinoza, E. O., Mann, M. J., Bleasdell, B. Arsenic and mercury in traditional Chinese herbal balls. N. Engl. J. Med. 333, 803-804 (1995).
41. Natori, S. Application of herbal drugs to health care in Japan. J. Ethnopharmacol. 2, 65-70 (1980).
42. Liu, C. et al. DNA barcode goes two-dimensions: DNA QR code web server. PloS one 7, e35146 (2012).
43. Cheng, X. et al. Biological ingredient analysis of traditional Chinese medicine preparation based on high-throughput sequencing: the story for Liuwei Dihuang Wan. Sci. Rep. 4, 5147 (2014).
44. Coghlan, M. L. et al. Deep sequencing of plant and animal DNA contained within traditional Chinese medicines reveals legality issues and health safety concerns. PLoS Genet. 8, e1002657 (2012).
45. Chen, X., Li, Q., Li, Y., Qian, J., Han, J. Chloroplast genome of Aconitum barbatum var. puberulum (Ranunculaceae) derived from CCS reads using the PacBio RS platform. Front. Plant Sci. 6, 42 (2015).
46. Li, Q. et al. High-accuracy de novo assembly and SNP detection of chloroplast genomes using a SMRT circular consensus sequencing strategy. New Phytol. 204, 1041-1049 (2014).
47. Keller, A. et al. 5.8 S-28S rRNA interaction and HMM-based ITS2 annotation. Gene 430, 50-57 (2009).